Scottish tech company Novosound develops world’s first ultrasound blood pressure monitor
Summary
Unlike many academic institutions that have focused primarily on laboratory-based developments, we have successfully demonstrated the effectiveness of our system in real-world settings, including public spaces. This presentation further solidified the credibility and reliability of our system.Dave Hughes, CEO and Founder of Novosound, said:Cardiovascular diseases affect over half a billion people globally, leading to more than 20 million deaths in 2021 alone, according to the World Heart Federation. Novosound will be showcasing these innovative capabilities at CES 2025 in Las Vegas in January, reinforcing its position in the global wearable tech market and expanding its outreach to potential collaborators and users alike.Recently, Novosound completed a successful \xa32 million funding round led by Par Equity, with participation from Kelvin Capital, the University of the West of Scotland, and Scottish Enterprise. We can see the traction the company is gaining with some of the worlds largest corporate brands, with considerable commercial opportunities ahead in digital health and industrial monitoring markets.Kelvin Capital is excited to further support Novosound as they continue to push the boundaries of ultrasonic technology. We believe that Novosound is poised to achieve even greater milestones, and we are proud to support their journey towards global growth and success.Professor James Miller, Principal & Vice-Chancellor of the University of the West of Scotland, also commented: